Source: Annual Congress 2011 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. C. Grimmelt, M. Barker, F. Brasch, M. Gappa, M. Kappler, R. Kitz, C. Kroener, S. Lau, E. Lorenz, C. Pfannenstiel, M. Preosmans, J. Ripper, C. Werner, S. Zielen, M. Griese (Munich, Berlin, Bielefeld, Wesel, Frankfurt am Main, Frankfurt, Aachen, Leuven, Münster, Germany). Old and novel surfactant protein C (SP-C) mutations in children. Eur Respir J 2011; 38: Suppl. 55, 632

Member's Comments

No comment yet.

Related content which might interest you: Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Source: Eur Respir J 2011; 38: 985-987 Year: 2011 A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Surfactant protein-A (SP-A) expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Surfactant protein C mutations and familial pulmonary fibrosis: stuck in a loop on the scenic route Source: Eur Respir J, 59 (1) 2102147; 10.1183/13993003.02147-2021 Year: 2022 Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred Source: Eur Respir J 2011; 38: 861-869 Year: 2011 Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant Source: Eur Respir J, 59 (1) 2100267; 10.1183/13993003.00267-2021 Year: 2022 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Study of gene expression control elements of the human SP-A genes: Role of the 5‘UTR exon B Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins Source: Annual Congress 2011 - Lung cell biology Year: 2011 Methylprednisolone pulse treatment influences splicing of SFTPC mRNA and promotes processing of pro-SP-C protein in twins with SFTPC mutation Source: International Congress 2018 – Orphan diseases in children Year: 2018 Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Late-breaking abstract: Association between serum surfactant protein D (SP-D) and lung function measurements in self-reported healthy twins Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Immunolocalization of surfactant protein-a (SP-A) in the lungs of pneumocystis pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002